DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Barber EL, Zsiros E, Lurain JR, Rademaker A, Schink JC, Neubauer NL.
The combination of intravenous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian cancer.
J Gynecol Oncol 2013;
24: 258-64
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.